Pharma and Biotech
By Iain Gilbert
Date: Tuesday 09 Nov 2021
LONDON (ShareCast) - (Sharecast News) - Nanopore-based technology firm Oxford Nanopore Technologies updated its full-year revenue guidance on Tuesday following a "significant expansion" of its activities in a large customer project in the United Arab Emirates.
Oxford Nanopore said on Tuesday that it had been awarded a new 36-month contract with G42 Laboratory, under which it will provide devices, consumables and other support services worth approximately $68.0m.
The London-listed group stated the project was expected to generate revenues primarily after the year-end. Therefore, it opted to maintain its guidance for core life science research tools revenues (LSRT) of £105.0m-111.0m in 2021.
However, given the scale of the new contract, Oxford Nanopore said it was now introducing guidance for LSRT revenues of £135.0m-145.0m for the 2022 trading year and also upgraded its LSRT revenue guidance for 2023 to £170.0m-190.0m.
As of 0915 GMT, Oxford Nanopore shares were 5.41% at 575.0p.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 122.80p |
Change Today | 0.40p |
% Change | 0.33 % |
52 Week High | 208.20p |
52 Week Low | 86.55p |
Volume | 1,112,467 |
Shares Issued | 954.11m |
Market Cap | £1,171.65m |
Beta | 1.26 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:37 | 183,613 @ 122.72p |
17:05 | 100 @ 122.80p |
16:29 | 135 @ 124.00p |
16:29 | 747 @ 123.90p |
16:29 | 469 @ 123.90p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research